The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

A population-based study on the prevalence of NASH using scores validated against liver histology.

Author

  • Jenni Hyysalo
  • Ville T Männistö
  • You Zhou
  • Johanna Arola
  • Vesa Kärjä
  • Marja Leivonen
  • Anne Juuti
  • Nabil Jaser
  • Susanna Lallukka
  • Pirjo Käkelä
  • Sari Venesmaa
  • Marko Simonen
  • Juha Saltevo
  • Leena Moilanen
  • Eeva Korpi-Hyövalti
  • Sirkka Keinänen-Kiukaanniemi
  • Heikki Oksa
  • Marju Orho-Melander
  • Luca Valenti
  • Silvia Fargion
  • Jussi Pihlajamäki
  • Markku Peltonen
  • Hannele Yki-Järvinen

Summary, in English

Non-alcoholic steatohepatitis (NASH) is a leading cause of chronic liver disease in Western countries. Diagnosis of NASH requires a liver biopsy. We estimated the prevalence of NASH non-invasively in a population-based study using scores validated against liver histology.

Topic

  • Gastroenterology and Hepatology

Status

Published

Research group

  • Diabetes - Cardiovascular Disease

ISBN/ISSN/Other

  • ISSN: 0168-8278